These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease. Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831 [TBL] [Abstract][Full Text] [Related]
8. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease. Manral A; Saini V; Meena P; Tiwari M Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018 [TBL] [Abstract][Full Text] [Related]
9. New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease. Czarnecka K; Girek M; Wójtowicz P; Kręcisz P; Skibiński R; Jończyk J; Łątka K; Bajda M; Walczak A; Galita G; Kabziński J; Majsterek I; Szymczyk P; Szymański P Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466601 [TBL] [Abstract][Full Text] [Related]
10. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease. Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607 [TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease. Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease. Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075 [TBL] [Abstract][Full Text] [Related]
13. Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation. Xu A; He F; Zhang X; Li X; Ran Y; Wei C; James Chou C; Zhang R; Wu J Bioorg Chem; 2020 May; 98():103721. PubMed ID: 32193030 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease. Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and activity evaluation of novel multitargeted l-tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease. Zeng X; Cheng S; Li H; Yu H; Cui Y; Fang Y; Yang S; Feng Y Arch Pharm (Weinheim); 2024 May; 357(5):e2300603. PubMed ID: 38290060 [TBL] [Abstract][Full Text] [Related]
16. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents. Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343 [TBL] [Abstract][Full Text] [Related]
17. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease. Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease. Zhang C; Du QY; Chen LD; Wu WH; Liao SY; Yu LH; Liang XT Eur J Med Chem; 2016 Jun; 116():200-209. PubMed ID: 27061983 [TBL] [Abstract][Full Text] [Related]
19. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents. Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006 [TBL] [Abstract][Full Text] [Related]